Nitrofurantoin Safety and Efficacy

Treatment Guidelines

The American Urological Association recommends nitrofurantoin as a preferred agent during pregnancy due to its safety profile, along with β-lactam antimicrobials, with a treatment duration of 4-7 days rather than single-dose therapy, as single-dose regimens are less effective and associated with lower birth weight (RR 1.65, 95% CI 1.06-2.57) 1
The standard dosing for nitrofurantoin is 100 mg twice daily for 5-7 days, according to clinical guidelines 1

Acute pulmonary reactions occur at extremely low rates (0.001%) and are believed to be immune-mediated rather than dose-dependent, with symptoms including fever, chills, cough, chest pain, dyspnea, pulmonary infiltration with consolidation or pleural effusion, and eosinophilia, and are reversible with immediate cessation of therapy 2
Hepatic reactions occur at extremely low rates (0.0003%) and include hepatitis, cholestatic jaundice, chronic active hepatitis, and hepatic necrosis 2

Regular assessment for adverse effects is necessary during prophylactic use, which typically lasts 6-12 months, with severe adverse effects occurring at frequencies of 0.02-1.5 per 1,000 nitrofurantoin users, and the risk of severe toxicity increasing with duration of prophylaxis 2